CN103948882A - Traditional Chinese medicine for treating thrombus - Google Patents
Traditional Chinese medicine for treating thrombus Download PDFInfo
- Publication number
- CN103948882A CN103948882A CN201410067972.2A CN201410067972A CN103948882A CN 103948882 A CN103948882 A CN 103948882A CN 201410067972 A CN201410067972 A CN 201410067972A CN 103948882 A CN103948882 A CN 103948882A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- parts
- rhizoma
- radix
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention belongs to the technical field of medicines, the present invention discloses a traditional Chinese medicine for treating thrombus diseases, and the traditional Chinese medicine is composed of the following traditional Chinese medicines: 50-100 parts of stigma croci, 70-150 parts of ginseng, 70-150 parts of leech, 80-160 parts of pseudo-ginseng, 60-100 parts of polygonatum rhizome, 80-170 parts of red sage root, 80-160 parts of radix astragali, 60-150 parts of curcuma zedoary, 60-100 parts of trigonous and 40-90 parts of dried ginger. The traditional Chinese medicine has the effects of dissolving thrombus in body, clearing garbage in blood, improving blood circulation, increasing the oxygen content in the blood, effective prevention and treatment of cardiovascular and cerebrovascular diseases, warming spleen and stomach for dispelling cold, and invigorating spleen-stomach and replenishing qi, and at the same time the traditional Chinese medicine can soften and dilate blood vessels and break through main and collateral channels, acupoints, and qi and blood.
Description
Technical field
The present invention relates to medical technical field, relate in particular to a kind of Chinese medicine for the treatment of thrombosis.
Background technology
The numeral of announcing according to health ministry shows, the number of dying from every year cardiovascular and cerebrovascular disease accounts for 85% of whole death toll, wherein only heart infarction hinders dead number and just reaches more than 50 ten thousand, the salvage success rate of heart infarction resistance is less than 1%, cardiovascular and cerebrovascular disease is the first killer of human health, yet the arch-criminal of cardiovascular and cerebrovascular disease is exactly thrombosis.
Thrombosis is the insoluble fiber albumen in human body, the platelet of deposition, superfluous fat, the formed blood rubbish of the various toxin such as free radical and impurity.
Sick from blood, blood is that life is basic, and kind good brain is lived century-old.When heart coronary artery thromboembolism, more than 30% will breast to occur vexed, breathe hard, nervous, more than 70% there is heart failure in heart coronary artery blood vessel embolism, now need pacemaker or bridging, or peace support, more seriously thrombi is stopped up suddenly heart arter blood vessel and heart infarction death can be occurred, cerebral blood vessel wall thromboembolism can cause senile dementia simultaneously, brain atrophy, more seriously thrombi is stopped up suddenly cerebral artery vessel and can be caused cerebral infarction death or apoplexy sequela, can cause the exhaustion of all internal organs in addition, also can cause tremulous pulse, vein blood vessel diminishes blood vessel effective diameter of pipe because of the formation of thrombosis, under the prerequisite that now blood flow is constant, flow velocity must strengthen, flow velocity strengthens and pressure must strengthen, this is the basic reason that hypertension forms, the capillary embolism of while blood vessel wall, cause sclerosis of blood vessels, now resistance of blood flow strengthens, resistance strengthens pressure and strengthens, this is again to form hypertensive another reason, also be the basic reason of cerebral hemorrhage and Cataractogenesis and each internal organs exhaustion.
Effect extreme difference due to existing medical skill treatment and prevention cardiovascular and cerebrovascular disease, the number of dying from every year cardiovascular and cerebrovascular disease accounts for 85% of whole death toll, wherein only heart infarction hinders dead number and just reaches more than 50 ten thousand, the salvage success rate of heart infarction resistance is less than 1%, cardiovascular and cerebrovascular disease is the first killer of human health, the whole nation comprises that the whole world there is no effect method to getting except human thrombus since the dawn of human civilization, in the face of the first killer of human health feels simply helpless.
Summary of the invention
The present invention is according to the origin cause of formation of thrombosis, and carries out targetedly prescription according to the principle of traditional Chinese medical science table, inner, cold, hot, empty, reality, yin, yang differentiation of eight pricipales, and a kind of Chinese medicine for the treatment of thrombosis is provided.
The technical scheme that the present invention takes is:
The Chinese medicine for the treatment of thrombosis of the present invention is comprised of following several Chinese medicine: Stigma Croci 50-100, Radix Ginseng 70-150, Hirudo 70-150, Radix Notoginseng 80-160, Rhizoma Polygonati 60-100, Radix Salviae Miltiorrhizae 80-170, Radix Astragali 80-160, Rhizoma Curcumae 60-150, Rhizoma Sparganii 60-100, Rhizoma Zingiberis 40-90.
Preferred: described Chinese medicine is comprised of the raw material of following weight portion: Stigma Croci 60-90, Radix Ginseng 90-130, Hirudo 90-120, Radix Notoginseng 100-140, Rhizoma Polygonati 70-90, Radix Salviae Miltiorrhizae 100-150, Radix Astragali 100-130, Rhizoma Curcumae 80-120, Rhizoma Sparganii 70-90, Rhizoma Zingiberis 50-80.
As one of preferential technical scheme: described Chinese medicine is comprised of following several Chinese medicine: Stigma Croci 50, Radix Ginseng 150, Hirudo 70, Radix Notoginseng 160, Rhizoma Polygonati 60, Radix Salviae Miltiorrhizae 170, the Radix Astragali 80, Rhizoma Curcumae 150, Rhizoma Sparganii 60, Rhizoma Zingiberis 90.
As one of preferential technical scheme: described Chinese medicine is comprised of the raw material of following weight portion: Stigma Croci 100, Radix Ginseng 70, Hirudo 150, Radix Notoginseng 80, Rhizoma Polygonati 100, Radix Salviae Miltiorrhizae 80, the Radix Astragali 160, Rhizoma Curcumae 60, Rhizoma Sparganii 100, Rhizoma Zingiberis 40.
As one of preferential technical scheme: described Chinese medicine is comprised of the raw material of following weight portion: Stigma Croci 80, Radix Ginseng 110, Hirudo 100, Radix Notoginseng 120, Rhizoma Polygonati 80, Radix Salviae Miltiorrhizae 120, the Radix Astragali 120, Rhizoma Curcumae 100, Rhizoma Sparganii 80, Rhizoma Zingiberis 70.
Described Hirudo is through frying with Oryza glutinosa.
The dosage form of the Chinese medicine for the treatment of thrombosis of the present invention is a kind of in electuary, decoction, tablet, capsule or injection.
Instructions of taking: above-mentioned Chinese medicine is total to porphyrize powder, every day three times, each 10 grams, takes with boiled water.
Good effect of the present invention is as follows:
Medicine of the present invention has the thrombus in vivo of melting, and removes the rubbish in blood, strengthens blood circulation, improves the oxygen content in blood, effectively prevents and treat cardiovascular and cerebrovascular disease, also has the effect of warming spleen and stomach for dispelling cold and invigorating the spleen and replenishing QI simultaneously.Can also soften with blood vessel dilating the meridian dredging, lead to acupuncture point, venting QI-blood simultaneously.
The specific embodiment
The following examples are to describe in further detail of the present invention.
Embodiment 1
Chinese medicine of the present invention is comprised of following several Chinese medicine: Stigma Croci 50, Radix Ginseng 150, Hirudo 70, Radix Notoginseng 160, Rhizoma Polygonati 60, Radix Salviae Miltiorrhizae 170, the Radix Astragali 80, Rhizoma Curcumae 150, Rhizoma Sparganii 60, Rhizoma Zingiberis 90.
Embodiment 2
Chinese medicine of the present invention is comprised of following several Chinese medicine: Stigma Croci 100, Radix Ginseng 70, Hirudo 150, Radix Notoginseng 80, Rhizoma Polygonati 100, Radix Salviae Miltiorrhizae 80, the Radix Astragali 160, Rhizoma Curcumae 60, Rhizoma Sparganii 100, Rhizoma Zingiberis 40.
Embodiment 3
Chinese medicine of the present invention is comprised of following several Chinese medicine: Stigma Croci 80, Radix Ginseng 110, Hirudo 100, Radix Notoginseng 120, Rhizoma Polygonati 80, Radix Salviae Miltiorrhizae 120, the Radix Astragali 120, Rhizoma Curcumae 100, Rhizoma Sparganii 80, Rhizoma Zingiberis 70.
Embodiment 4
Chinese medicine of the present invention is comprised of following several Chinese medicine: Stigma Croci 60, Radix Ginseng 130, Hirudo 90, Radix Notoginseng 140, Rhizoma Polygonati 70, Radix Salviae Miltiorrhizae 150, the Radix Astragali 100, Rhizoma Curcumae 120, Rhizoma Sparganii 70, Rhizoma Zingiberis 80.
Embodiment 5
Chinese medicine of the present invention is comprised of following several Chinese medicine: Stigma Croci 90, Radix Ginseng 90, Hirudo 120, Radix Notoginseng 100, Rhizoma Polygonati 90, Radix Salviae Miltiorrhizae 100, the Radix Astragali 130, Rhizoma Curcumae 80, Rhizoma Sparganii 90, Rhizoma Zingiberis 50.
Clinical efficacy:
Existing 876 people took medicine of the present invention for this reason up till now, took and took effect a course for the treatment of (30 days), and total effective rate is 98%, and taking three to five courses for the treatment of (90 as for 150 days) cure rates is 85%, nontoxic in therapeutic process, have no side effect, no dependence.
Model case:
1, Zhang Shuping, female, 48 years old, people from Urumchi, because thrombosis causes sensation of oppression over the chest with shortness of breath, dysphonia, took action ineffective more than ten years after diagnosing, takes Western medicine for many years before, and unsatisfactory curative effect, takes medicine of the present invention always, after 30 days, thoroughly recovery from illness, and lose weight 9 kilograms.After half a year, pay a return visit, without recurrence.
2, Li Yulong, man, 85 years old, people from Kunming, because thrombosis causes coronary heart disease 20 years, take before Drug therapy of the present invention long-term oxygen uptake, walking asthma, take not Cui of Western medicine and other Chinese medicine effect throughout the year, take medicine of the present invention and be almost recovered after 150 days, can normally take action and can run.
3, Ma Kunjing, 52 years old, people from Kunming, had 5 years because thrombosis causes hypertension, takes medicine of the present invention after 30 days, detected health recovery from illness, and after 1 year, body constitution is good.
4, Gu Xianzhong, 65 years old, people from Kunming, cause tens kinds of diseases such as coronary heart disease because of thrombosis, will take tens kinds of medicines every day, for a long time at many large hospitals not Cui of benefit that receives treatment, take medicine of the present invention and be almost recovered after 30 days, can normally take action and can run, greatly improved quality of life.
Although illustrated and described embodiments of the invention, for the ordinary skill in the art, be appreciated that without departing from the principles and spirit of the present invention and can carry out multiple variation, modification, replacement and modification to these embodiment, scope of the present invention is limited by claims and equivalent thereof.
Claims (7)
1. a Chinese medicine for the treatment of thrombosis, is characterized in that: described Chinese medicine is comprised of following several Chinese medicine: Stigma Croci 50-100, Radix Ginseng 70-150, Hirudo 70-150, Radix Notoginseng 80-160, Rhizoma Polygonati 60-100, Radix Salviae Miltiorrhizae 80-170, Radix Astragali 80-160, Rhizoma Curcumae 60-150, Rhizoma Sparganii 60-100, Rhizoma Zingiberis 40-90.
2. the Chinese medicine for the treatment of thrombosis as claimed in claim 1, is characterized in that: described Chinese medicine is comprised of following several Chinese medicine: Stigma Croci 60-90, Radix Ginseng 90-130, Hirudo 90-120, Radix Notoginseng 100-140, Rhizoma Polygonati 70-90, Radix Salviae Miltiorrhizae 100-150, Radix Astragali 100-130, Rhizoma Curcumae 80-120, Rhizoma Sparganii 70-90, Rhizoma Zingiberis 50-80.
3. the Chinese medicine for the treatment of thrombosis as claimed in claim 1, is characterized in that: described Chinese medicine is comprised of following several Chinese medicine: Stigma Croci 50, Radix Ginseng 150, Hirudo 70, Radix Notoginseng 160, Rhizoma Polygonati 60, Radix Salviae Miltiorrhizae 170, the Radix Astragali 80, Rhizoma Curcumae 150, Rhizoma Sparganii 60, Rhizoma Zingiberis 90.
4. the Chinese medicine for the treatment of thrombosis as claimed in claim 1, is characterized in that: described Chinese medicine is comprised of following several Chinese medicine: Stigma Croci 100, Radix Ginseng 70, Hirudo 150, Radix Notoginseng 80, Rhizoma Polygonati 100, Radix Salviae Miltiorrhizae 80, the Radix Astragali 160, Rhizoma Curcumae 60, Rhizoma Sparganii 100, Rhizoma Zingiberis 40.
5. the Chinese medicine for the treatment of thrombosis as claimed in claim 1, is characterized in that: described Chinese medicine is comprised of following several Chinese medicine: Stigma Croci 80, Radix Ginseng 110, Hirudo 100, Radix Notoginseng 120, Rhizoma Polygonati 80, Radix Salviae Miltiorrhizae 120, the Radix Astragali 120, Rhizoma Curcumae 100, Rhizoma Sparganii 80, Rhizoma Zingiberis 70.
6. the Chinese medicine of the treatment thrombosis as described in claim 1-5 any one, is characterized in that: described Hirudo is through frying with Oryza glutinosa.
7. the Chinese medicine of the treatment thrombosis as described in claim 1-5 any one, is characterized in that: the dosage form of described Chinese medicine is a kind of in electuary, decoction, tablet, capsule or injection.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410067972.2A CN103948882A (en) | 2014-02-27 | 2014-02-27 | Traditional Chinese medicine for treating thrombus |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410067972.2A CN103948882A (en) | 2014-02-27 | 2014-02-27 | Traditional Chinese medicine for treating thrombus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103948882A true CN103948882A (en) | 2014-07-30 |
Family
ID=51326322
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410067972.2A Pending CN103948882A (en) | 2014-02-27 | 2014-02-27 | Traditional Chinese medicine for treating thrombus |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103948882A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104274696A (en) * | 2014-10-15 | 2015-01-14 | 高用谋 | Traditional Chinese medicine for preventing and treating heart disease, cerebral hemorrhage, cerebral infarction and preparation method thereof |
| CN104324325A (en) * | 2014-10-30 | 2015-02-04 | 梁春林 | Traditional Chinese medicine composition for dredging vessels and dissolving thrombosis and preparation method thereof |
| CN110812462A (en) * | 2019-12-11 | 2020-02-21 | 刘德平 | Traditional Chinese medicine composition for removing blood stasis, dredging collaterals and removing speckles and application thereof |
| CN114344435A (en) * | 2022-01-11 | 2022-04-15 | 中优尚品(广州)生物科技有限公司 | Thrombolytic oral bacteriostatic spray and preparation method thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1709321A (en) * | 2005-06-14 | 2005-12-21 | 吉林长白山药业集团股份有限公司 | Capsule for radix astragalis and red-rooted salvia root |
| KR100805865B1 (en) * | 2006-07-26 | 2008-02-21 | 한국 한의학 연구원 | Anti-thrombus agent comprising extract of herbal mixture |
| CN101569695A (en) * | 2008-04-30 | 2009-11-04 | 北京卓越同创药物研究院 | Medicament composition for curing cardiovascular and cerebrovascular diseases |
-
2014
- 2014-02-27 CN CN201410067972.2A patent/CN103948882A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1709321A (en) * | 2005-06-14 | 2005-12-21 | 吉林长白山药业集团股份有限公司 | Capsule for radix astragalis and red-rooted salvia root |
| KR100805865B1 (en) * | 2006-07-26 | 2008-02-21 | 한국 한의학 연구원 | Anti-thrombus agent comprising extract of herbal mixture |
| CN101569695A (en) * | 2008-04-30 | 2009-11-04 | 北京卓越同创药物研究院 | Medicament composition for curing cardiovascular and cerebrovascular diseases |
Non-Patent Citations (4)
| Title |
|---|
| 刘海涛等: "《实用临床诊疗学》", 30 September 2008, article "五.治疗", pages: 3 - 1 * |
| 李梅: "《中医药学基础》", 31 August 2009, article "干姜", pages: 246 * |
| 蔡少青等: "《常用中药材品种整理和质量研究第5册》", 31 May 2001, article "采集与炮制", pages: 602 - 3 * |
| 霍锡坚: "通脉络汤治疗脑血栓形成22例", 《山西中医》, vol. 10, no. 4, 31 December 1994 (1994-12-31), pages 27 - 3 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104274696A (en) * | 2014-10-15 | 2015-01-14 | 高用谋 | Traditional Chinese medicine for preventing and treating heart disease, cerebral hemorrhage, cerebral infarction and preparation method thereof |
| CN104324325A (en) * | 2014-10-30 | 2015-02-04 | 梁春林 | Traditional Chinese medicine composition for dredging vessels and dissolving thrombosis and preparation method thereof |
| CN110812462A (en) * | 2019-12-11 | 2020-02-21 | 刘德平 | Traditional Chinese medicine composition for removing blood stasis, dredging collaterals and removing speckles and application thereof |
| CN114344435A (en) * | 2022-01-11 | 2022-04-15 | 中优尚品(广州)生物科技有限公司 | Thrombolytic oral bacteriostatic spray and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101181600B (en) | Traditional Chinese medicine composition for curing cardiovascular and cerebrovascular diseases | |
| CN103948882A (en) | Traditional Chinese medicine for treating thrombus | |
| CN102626476A (en) | Medicine for treating and preventing ischemic cardiovascular and cerebrovascular diseases | |
| CN104258350A (en) | Traditional Chinese medicine preparation for treating sick sinus syndrome and preparation method of traditional Chinese medicine preparation | |
| CN106236833A (en) | A kind of pharmaceutical composition treating cardiovascular and cerebrovascular disease | |
| CN105963547A (en) | Health medicinal liquor capable of treating insomnia and preparation method of health medicinal liquor | |
| CN107243022A (en) | Traditional Chinese medicine pill for the treatment of cancer and preparation method thereof | |
| CN104208643A (en) | Chinese medicine for treating hemiplegia and preparation method thereof | |
| CN103920005B (en) | Medicine is intervened before a kind of neurosurgery general anesthesia patients | |
| CN102512645A (en) | Traditional Chinese medicine composition for treating lumbago due to cold dampness | |
| CN103893564B (en) | A kind of pharmaceutical composition suitable in the preoperative use of craniocerebral operations | |
| CN103961603B (en) | Traditional Chinese medicine preparationcapable of reducing blood fat and freeing vessels | |
| CN103948880B (en) | Traditional Chinese medicine for treating arrhythmia | |
| CN107837383A (en) | A kind of traditional Chinese powder medicine for treating cardiovascular and cerebrovascular diseases | |
| CN106983825A (en) | It is a kind of to be used to treat Chinese medicine composition of cerebral thrombus and its preparation method and application | |
| CN102078533A (en) | Drug for treating hypertension | |
| CN102058842A (en) | Traditional Chinese medicine composition for treating hemiplegic stroke or premonitory apoplexy | |
| CN103800723A (en) | Traditional Chinese medicine composition for treating arrhythmia and preparation method of composition | |
| CN103751616B (en) | Pharmaceutical composition for the treatment of autonomic nervous dysfunction and its production and use | |
| CN104189539A (en) | Traditional Chinese medicine for treating allergic rhinitis | |
| CN103933355B (en) | Capsule of postoperative rigor incidence rate and preparation method thereof can be reduced | |
| CN103356951A (en) | Traditional Chinese medicine composition for treating cardiac insufficiency | |
| CN103006868A (en) | Traditional Chinese medicine composition for treating Behcet diseases | |
| CN102526612A (en) | Traditional Chinese medicine composite for curing angina pectoris | |
| CN106728849A (en) | A kind of medicine pill for treating acute leukemia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140730 |